Skip to contentG
Gilead Sciences, Inc.
G
GILDGilead Sciences, Inc. Source filing unavailable
Q1 2012 · —
Revenue$2.28B$2.28B+18.5% vs Q1 2011 Net Income$441.96M$441.96M−32.1% vs Q1 2011 EPS Diluted$0.28$0.28−30.0% vs Q1 2011 Gross Profit$1,627,411,000+17.1% Operating Income$800,186,000−11.3% Operating Cash Flow$452,969,000
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gilead Sciences, Inc. · CIK 882095 · Engraved from SEC EDGAR
−44.8%
Free Cash Flowderived$429,770,000−46.7% Margins · derivedGross margin71.3%−0.8 pt vs Q1 2011
Operating margin35.1%−11.8 pt vs Q1 2011
Net margin19.4%−14.4 pt vs Q1 2011